CYTOGEL PHARMA LLC has a total of 41 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets pharmaceuticals, biotechnology and machines are S I S SHULOV INNOVATIVE SCIENCE LTD, BIOEXPERTISE LLC and TXP PHARMA GMBH.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 16 | |
#2 | EPO (European Patent Office) | 8 | |
#3 | Australia | 5 | |
#4 | Canada | 5 | |
#5 | WIPO (World Intellectual Property Organization) | 4 | |
#6 | China | 2 | |
#7 | Hong Kong | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Maione Theodore E | 35 |
#2 | Maglaris Constantine Basil | 13 |
#3 | Hamsher James | 6 |
#4 | Maione Theodore | 5 |
#5 | Carozza Joseph | 5 |
#6 | Maglaris Constantine | 3 |
#7 | Maglaris C Dean | 3 |
#8 | Maglaris Dean C | 2 |
#9 | Chu Chih-Chang | 1 |
#10 | Wu Daqing | 1 |
Publication | Filing date | Title |
---|---|---|
EP3710467A2 | Polymer agonists of mu opioid receptors | |
CN111683654A | Novel analgesic pharmaceutical preparation and use thereof | |
US2018371017A1 | Analgesic mu-opioid receptor binding peptide pharmaceutical formulations and uses thereof | |
US2015126455A1 | Novel Therapeutic Uses of Mu-Opiate Receptor Peptides | |
CA2797892A1 | Materials and methods for treatment of inflammation | |
US2011151004A1 | Injectable microspheres | |
WO2011034659A2 | Advantageous mu-opiate receptor peptide compounds | |
CA2984218A1 | Advantageous salts of mu-opiate receptor peptides |